yingweiwo
  1. Home
  2. Products
  3. Signaling Pathways
  4. PI3K / Akt / mTOR
  5. mTOR

mTOR

mTOR

mTOR related products

Structure Cat No. Product Name CAS No. Product Description
(+)-松萝酸 V2177 (+)-Usniacin 7562-61-0 Usniacin, [(+)-Usnic acid] is a natually occuring compound isolated from lichens, which binds at the ATP-binding pocket of mTOR, and inhibits mTORC1/2 activity.
4-TCPA V126522 4-TCPA 4-TCPA is a potent VEGFR2 inhibitor.
Anti-inflammatory agent 107 V129056 Anti-inflammatory agent 107 Anti-inflammatory agent 107 is an orally effective anti-inflammatory drug.
ATM-IN-2 V129598 ATM-IN-2 ATM-IN-2 is a highly selective, orally effective ATM inhibitor with an IC50 value of 4 nM.
ATR-IN-31 V129631 ATR-IN-31 2954923-16-9 ATR-IN-31 is a selective ATR kinase inhibitor with an IC50 value of 7 nM.
AZD8055 V0177 AZD8055 1009298-09-2 AZD8055 is a novel, potent selective, and orally bioavailableATP-competitive mTOR (mammalian target of rapamycin) inhibitor with potential anticancer activity.
GDC-0349 (RG7603) V0205 GDC-0349 (RG7603) 1207360-89-1 GDC-0349(also known asRG-7603) is a novel, potent,orally bioavailable and selective ATP-competitive inhibitor of mTOR (mammalian target of rapamycin) with potential antitumor activity.
GSK3β/mTOR modulator 1 V136973 GSK3β/mTOR modulator 1 GSK3β/mTOR modulator 1 is a modulator of the GSK3β/mTOR signaling pathway.
KRAS IN-44 V138495 KRAS IN-44 KRAS IN-44 is a PDE6D degrading agent.
KU-0063794 V0179 KU-0063794 938440-64-3 KU-0063794 is a novel, potent, cell permeable and selective inhibitor of mTOR (mammalian target of rapamycin) with potential anticancer activity.
Levomilnacipran-d5 hydrochloride V138806 Levomilnacipran-d5 hydrochloride Levomilnacipran-d5 hydrochloride is the deuterated levomilnacipran hydrochloride.
LGB321 monohydrochloride V84608 LGB321 monohydrochloride 1469925-36-7
Methionyl-methionine V139727 Methionyl-methionine 52715-93-2 Methionylmethionine (Met-Met) significantly promotes the expression of α-s1 casein (αS1-CN) in mammary explants by enhancing intracellular substrate availability and activating JAK2-STAT5 and mTOR-mediated signaling pathways.
MHY1485 V0209 MHY1485 326914-06-1 MHY1485 is a novel, potent andcell-permeable activator of mTOR(mammalian target of rapamycin) and an inhibitor of autophagy that suppress the fusion between autophagosomes and lysosomes.
mTOR inhibitor WYE-28 V70239 mTOR inhibitor WYE-28 1062172-60-4 mTOR inhibitor WYE-28 (compound 28) is a selective inhibitor of mTOR (IC50=0.08 nM).
mTOR inhibitor-13 V70257 mTOR inhibitor-13 1144075-44-4 mTOR inhibitor-13 (compound 9g) is an arylurea-based compound and is a potent and specific mTOR inhibitor (antagonist) with IC50 of 0.29 nM.
mTORC1-IN-2 V70258 mTORC1-IN-2 2974368-96-0 mTORC1-IN-2 (compound H3) is a NO donor compound that alleviates vasodilation and myocardial hypoxic injury.
OSI-027 (ASP-4786, CERC-006, AEVI-006) V0189 OSI-027 (ASP-4786, CERC-006, AEVI-006) 936890-98-1 OSI-027 (formerly known as ASP4786; AEVI006; CERC006) is a novel, potent, selective, orally bioavailable and ATP-competitive dual inhibitor of mTORC1 (mammalian target of rapamycin 1) and mTORC2with potential anticancer activity.
Palomid 529 (P-529, SG00-529) V0199 Palomid 529 (P-529, SG00-529) 914913-88-5 Palomid 529 (also called P529, SG00-529), developed byPaloma Pharmaceuticals, isanovel and potent inhibitor of mTOR (mammalian target of rapamycin) with potential antitumor activity.
Pertuzumab-LD3 V142486 Pertuzumab-LD3 Pertuzumab-LD3 is a humanized antibody-drug conjugate (ADC) that targets HER2.
Contact Us
Tel: 1-708-310-1919 Fax: 1-708-557-7486 Email: [email protected] Frequently Asked Questions
Subscribe to our E-newsletter
Name
E-mail

Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved

linkedin facebook
Contact Us
Home Product Cart Member